Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
14.07
+0.39 (2.85%)
At close: May 27, 2026, 4:00 PM EDT
14.05
-0.02 (-0.14%)
After-hours: May 27, 2026, 7:32 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.56 billion as of May 27, 2026. Its market cap has increased by 280.69% in one year.
Market Cap
1.56B
Enterprise Value
1.29B
1-Year Change
280.69%
Ranking
Category
Stock Price
$14.07
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.56B, an increase of 46.31%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.52B | 14.65% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioCryst Pharmaceuticals | 2.15B |
| Bausch Health Companies | 2.02B |
| HUTCHMED (China) | 2.02B |
| ANI Pharmaceuticals | 1.73B |
| Perrigo Company | 1.49B |
| Phibro Animal Health | 1.37B |
| Harrow | 1.27B |
| Collegium Pharmaceutical | 1.10B |